The evolution of pharmaceutical care for drug misusers.

BACKGROUND In the last 20 years, pharmaceutical care has evolved as a modus operandi for community pharmacy. This article tracks the development of pharmaceutical care for drug misusers since 1995 and considers the implications for pharmacy engagement with the wider care team. OBJECTIVE To survey current community pharmacy service provision for drug misusers, past training and future training needs and compare with data from previous years (1995, 2000 and 2006). METHOD A cross-sectional postal questionnaire of pharmacy managers in Scotland (n = 1246), and telephone interviews with non-respondents. Results were compared with previous surveys. RESULTS The response rate was 70% (873) including 13.2% (164) by telephone. More pharmacies dispensed methadone in 2014 (88.5%) than previously, a significant increase across all time points (1995, 2000 and 2006) (P < 0.001). Most pharmacies (88.1%) had some drug misusers registered for the minor ailment scheme. In 2014, 43.4% of pharmacists always reported a drug misuser's non-attendance for opiate replacement treatment (ORT) to the prescriber (36.6% in 2006). If patient intoxication was suspected, medication was always withheld by 47.9% (27.5% in 2006). Pharmacists undertaking training in drug misuse and blood-borne diseases increased significantly since 1995, to 78.6% and 48.7%, respectively, in 2014 (P < 0.001). The preferred topic for future training was communication/engagement with other services. CONCLUSION Pharmaceutical care for drug misusers has evolved from ORT supply to a more clinical approach. Pharmacists actively monitored ORT patients, managed their minor ailments and increasingly engaged with the wider care team.

[1]  E. Brouwers,et al.  Stigma among health professionals towards patients with substance use disorders and its consequences for healthcare delivery: systematic review. , 2013, Drug and alcohol dependence.

[2]  Gerry McCartney,et al.  Health Inequalities in Scotland: Looking beyond the blame game , 2011 .

[3]  J. Luty,et al.  Stigmatised attitudes in independent pharmacies associated with discrimination towards individuals with opioid dependence , 2010 .

[4]  A. Winstock,et al.  Patients' help-seeking behaviours for health problems associated with methadone and buprenorphine treatment. , 2008, Drug and alcohol review.

[5]  C. Bond,et al.  Community pharmacy harm reduction services for drug misusers: national service delivery and professional attitude development over a decade in Scotland. , 2007, Journal of public health.

[6]  T. Johnson,et al.  Methodologies for Improving Response Rates in Surveys of Physicians , 2007, Evaluation & the health professions.

[7]  J. Strang,et al.  Community pharmacies and the provision of opioid substitution services for drug misusers: changes in activity and attitudes of community pharmacists across England 1995-2005. , 2007, Addiction.

[8]  C. Bond,et al.  Community pharmacy services for drug misusers in Scotland: what difference does 5 years make? , 2002, Addiction.

[9]  C. Bond,et al.  Prescribing and dispensing for drug misusers in primary care: current practice in Scotland. , 1999, Family practice.

[10]  C. Matheson Views of illicit drug users on their treatment and behaviour in Scottish community pharmacies: implications for the harm-reduction strategy , 1998 .

[11]  C. Matheson PRIVACY AND STIGMA IN THE PHARMACY : ILLICIT DRUG USERS' PERSPECTIVES AND IMPLICATIONS FOR PHARMACY PRACTICE , 1998 .

[12]  C. Hepler,et al.  Opportunities and responsibilities in pharmaceutical care. , 1990, American journal of hospital pharmacy.